Digital Breast Tomosynthesis Equipment Market, by Product Type (Equipment, and Upgradation) By End User (Hospitals, and Diagnostic Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Digital breast tomosynthesis (DBT) serves as an innovative medical imaging technique that relies on x-rays for creating highly detailed three dimensional images of the breasts. This cutting edge technology surpasses traditional mammography as the primary screening tool for detecting early indications of breast cancer. During DBT caregivers compress each breast while capturing multiple low dose X ray scans from varying angles; then they utilize specialized software for arranging these scans into a set of three dimensional images known as tomograms. By examining each slice in these tomograms one by one radiologists acquire unparalleled visibility amid overlapping tissues within the breasts—allowing them greater precision in identifying any abnormalities hidden within this complex tissue. Research has demonstrated that DBT enhances the outcomes of breast cancer screening by increasing detection rates while simultaneously decreasing false positive results compared to traditional mammography alone. For women with dense breasts who require routine screening for early signs of breast cancer, DBT is generally used alongside mammography and demonstrates a high degree of safety and tolerability. However, similar to mammography DBT does expose the patient’s breasts to ionizing radiation. It has been widely acknowledged that the advantages of catching breast cancer in its early stages far surpass any possible negative outcomes linked to radiation exposure. In other words detecting this disease early on can lead to a higher chance of survival for patients, which is a top priority for medical professionals and society as a whole.
Market Dynamics
The rising incidence of breast cancer worldwide is the main factor driving the global market for digital breast tomosynthesis equipment. The market has grown even more due to improvements in image quality and lower radiation exposure for patients brought on by developments in digital breast tomosynthesis technology. The value of early breast cancer screening is becoming more and more recognized by women, which has helped the market expand. For instance, in March 2021, according to the WHO (World Health Organization), in 2020 there were 2.3 million women diagnosed with breast cancer and 685000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years, making it the world’s most prevalent cancer.
Key features of the study:
This report provides an in-depth analysis of the global digital breast tomosynthesis equipment market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global digital breast tomosynthesis equipment market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Hologic, Inc., Internazionale Medico Scientifica-S.R.L, GE Healthcare, Siemens Healthineers, Fujifilm Corporation, Planmed OY, Trivitron Healthcare, Varex Imaging Corporation, and Analogic Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global digital breast tomosynthesis equipment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital breast tomosynthesis equipment market.
Detailed Segmentation:
Global Digital Breast Tomosynthesis Equipment Market, By Product Type:
Equipment
Upgradation
Global Digital Breast Tomosynthesis Equipment Market, By End User:
Hospitals
Diagnostic Centers
Global Digital Breast Tomosynthesis Equipment Market, By Region:
North America
By Country:
U.S.
Canada
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Country:
GCC
Israel
Rest of Middle East
Africa
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
Hologic, Inc. *
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Internazionale Medico Scientifica-S.R.L
GE Healthcare
Siemens Healthineers
Fujifilm Corporation
Planmed OY
Trivitron Healthcare
Varex Imaging Corporation
Analogic Corporation
“*” marked represents similar segmentation in other categories in the respective section